WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 44 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,260,678 | 25.95% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $9,168,128 | 4.91% |
| MPM BioImpact LLC | 2,388,011 | $5,110,344 | 1.36% |
| RA Capital Management | 6,144,881 | $13,150,045 | 0.26% |
| PFM Health Sciences, LP | 2,558,282 | $5,474,723 | 0.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,341,373 | 0.24% |
| Rubric Capital Management LP | 1,935,357 | $4,141,664 | 0.16% |
| Laurion Capital Management LP | 522,900 | $1,119,006 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $851,309 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 95,511 | $204,394 | 0.01% |